ProPharma recognizes that the recent increase in legislation broadening the scope of required transparency can be a challenge to navigate as you work to stay compliant while balancing your commercial obligations.
In response to this ProPharma developed a management consultation program as a complement to our clinical trial registry authoring and redaction services. Through this program we provide expert consultation and guidance to help with understanding, interpreting, and applying the relevant regulations to individual programs and studies.
In addition, we remain active participants in the clinical trials disclosure community, attending and participating in industry conferences, volunteering for working groups, attending workshops and seminars and collaborating with industry partners to stay abreast of evolving trends. Whenever possible, we share that knowledge with our clients to ensure compliance and improve efficiency.